Dharmesh Kant of Indianivesh Securities recommends buying Alembic Pharmaceuticals with a target of Rs 220 and Arvind with a target of Rs 136.
first published: Dec 23, 2013 11:54 am
A collection of the most-viewed Moneycontrol videos.

Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell

Live: Can Nifty claim new lifetime highs in December series? | Opening Bell

Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell

Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
You are already a Moneycontrol Pro user.

